Biomarkers and therapeutics targets

Group leader

María Laura García Bermejo

garciabermejo(ELIMINAR)@gmail.com

Tlf.: +34 91 3368075

Principal Investigators

  • Elisa Conde Moreno
  • Fernando Liaño García

Collaborators

  • Ángel Candela Toha
  • Miren Edurne Ramos Muñoz
  • Esperanza Macarena Rodríguez Serrano
  • Sara Gimenez Moyano
  • Lorena Crespo Toro
  • Laura Salinas Muñoz
  • Silvia Serrano Huertas
  • Carolina Pilar Blanco Agudo
  • Patricia Alonso Andres
Imagen equipo

Group leader

María Laura García Bermejo

garciabermejo(ELIMINAR)@gmail.com

Tlf.: +34 91 3368075

Principal Investigators

  • Elisa Conde Moreno
  • Fernando Liaño García

Collaborators

  • Ángel Candela Toha
  • Miren Edurne Ramos Muñoz
  • Esperanza Macarena Rodríguez Serrano
  • Sara Gimenez Moyano
  • Lorena Crespo Toro
  • Laura Salinas Muñoz
  • Silvia Serrano Huertas
  • Carolina Pilar Blanco Agudo
  • Patricia Alonso Andres

Strategic objectives 

Generation and validation of useful tools for diagnosis and prognosis, stratification and treatment of patients in different pathologies.

Research lines

  • Mechanisms of development of renal fibrosis. New biomarkers and therapeutic action targets in chronic renal disease (CRD)
  • Precise biomarkers of predisposition to and diagnosis and prognosis of acute renal failure (ARF)
  • New therapeutic targets in ARF
  • Mechanisms of polarisation of macrophages in nephropathies: potentials new therapeutic approaches in kidney inflammation
  • Physiopathological mechanisms in renal vasculitis: validation of new diagnostic tools and of patient stratification
  • New prognostic biomarkers in haemodialysis
  • miRNAs as new diagnostic and prognostic biomarkers in pancreatic cancer
  • New therapeutic action targets in pancreatic cancer: KIF3B
  • miRNAs as biomarkers in heart failure and mechanisms of cardiac remodelling
  • miRNas as stratification tools and new therapeutic action targets in colorectal cancer

Location

Biomarkers and Therapeutic Targets Lab

7th Floor right
Ramón y Cajal Hospital University
+34 91 336 80 75

Keywords

Biomarker, therapeutic targets, miRNAs, translational research, personalised medicine